Achieve Life Sciences stock forecast
Want to see QUIT full AI Analyst Report?
Achieve Life Sciences (QUIT) Stock Forecast & Price Target
QUIT Analyst Ratings
QUIT Stock 12 Month Forecast
Average Price Target
$13.29▲(105.98% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Walsh | JonesTrading | $10 | buy | 55.04%Upside | Reiterated | 11/12/26 | ||
| Brandon Folkes | H.C. Wainwright | $12 | buy | 86.05%Upside | Reiterated | 11/11/26 | ||
| Jason McCarthy | Maxim Group | $10 | buy | 55.04%Upside | Reiterated | 11/11/26 | ||
| Gary Nachman | Canaccord Genuity | $13 | buy | 101.55%Upside | Reiterated | 11/10/26 | ||
| Maxwell Skor | Morgan Stanley | $13 | buy | 101.55%Upside | Reiterated | 10/21/26 | ||
| Patrick Dolezal | LifeSci Capital | $17 | buy | 163.57%Upside | Reiterated | 10/21/26 | ||
| James Condulis | Stifel Nicolaus | $18 | buy | 179.07%Upside | Initiated | 09/30/26 | ||
| Ryan Deschner | Raymond James | $20 | buy | 210.08%Upside | Initiated | 06/26/26 | ||
| Mark Smith | Lake Street | $11 | buy | 70.54%Upside | Reiterated | 05/13/26 | ||
| Jason Butler | Citizens JMP | $19 | buy | 194.57%Upside | Initiated | 11/25/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin WalshJonesTrading | BuyReiterated$10 | 11/12/26 | 55.04%Upside | ||
| Brandon FolkesH.C. Wainwright | BuyReiterated$12 | 11/11/26 | 86.05%Upside | ||
| Jason McCarthyMaxim Group | BuyReiterated$10 | 11/11/26 | 55.04%Upside | ||
| Gary NachmanCanaccord Genuity | BuyReiterated$13 | 11/10/26 | 101.55%Upside | ||
| Maxwell SkorMorgan Stanley | BuyReiterated$13 | 10/21/26 | 101.55%Upside | ||
| Patrick DolezalLifeSci Capital | BuyReiterated$17 | 10/21/26 | 163.57%Upside | ||
| James CondulisStifel Nicolaus | BuyInitiated$18 | 09/30/26 | 179.07%Upside | ||
| Ryan DeschnerRaymond James | BuyInitiated$20 | 06/26/26 | 210.08%Upside | ||
| Mark SmithLake Street | BuyReiterated$11 | 05/13/26 | 70.54%Upside | ||
| Jason ButlerCitizens JMP | BuyInitiated$19 | 11/25/25 | 194.57%Upside |
Best Analysts Covering Achieve Life Sciences
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +32.90% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +75.05% per trade.
Copying Justin Walsh's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +75.62% per trade.
QUIT Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 9 | 13 | 10 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 12 | 10 | 14 | 10 |
In the current month, QUIT has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QUIT average Analyst price target in the past 3 months is 13.29.
QUIT Financial Forecast
QUIT Earnings Forecast
Next quarter’s earnings estimate for QUIT is -$0.21 with a range of -$0.36 to -$0.10. The previous quarter’s EPS was -$0.11. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
QUIT Sales Forecast
Next quarter’s sales forecast for QUIT is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
